Contact |
General |
Specializations in Countries |
Contribution to the Global Plan |
Declaration |
View this partner's profile
Focal Point Contact Information |
Salutation: |
Dr. |
First Name: |
Anna |
Last Name: |
Mandalakas |
Title: |
Director, Global Tuberculosis Program |
Email: |
anna.mandalakas@bcm.edu |
Phone: |
832-822-6730 |
|
Alternate Focal Point Contact Information |
Salutation: |
Mrs. |
First Name: |
Katherine |
Last Name: |
Ngo |
Title: |
Project Manager |
Email: |
katherine.ngo@bcm.edu |
Phone: |
832-824-0612 |
|
General Information |
Board Constituency: |
Technical agencies |
Is your organization legally registered in your country: |
Yes |
If yes, please enter your registration number: |
|
Organization Type - Primary: |
Academic / Research Institution |
Organization Type - Secondary: |
None |
Organization Description: |
The Global Childhood TB Program began in 2011 with the recruitment of world renown pediatric TB expert Dr. Anna Mandalakas to Baylor College of Medicine and Texas Children's Hospital in Houston, TX. As Director of the Global Childhood TB program, Dr. Mandalakas was commissioned by the World Health Organization (WHO) to perform an expert review of the diagnostic tool, geneXpert to inform policy making on childhood TB diagnostics.
The mission of The Global Tuberculosis (TB) Program is well aligned with the World Health Organization (WHO) Millenium Development Goals and uses the tools of research, education, and advocacy to prevent, diagnose, and treat tuberculosis in children. The long-term goal of our program is the establishment of a network of Childhood Tuberculosis Centers of Excellence built upon Texas Children’s existing clinical infrastructure in Sub-Saharan Africa. Our Global Childhood TB Program team works in four inter-related areas including disease prevention, diagnostics, treatment, and immunology. These program domains are built upon a data collection core and complemented by rigorous epidemiological and operational research.
The Global Childhood TB Program uses partnerships with other members of the Baylor College of Medicine family and collaborators at other institutions to develop effective, sustainable, standardized methods of diagnosing tuberculosis in children and is attempting to identify biomarkers correlating with progression from tuberculosis infection to disease, as well as standardizing screening processes to better characterize epidemiological risk factors for tuberculosis.
|
|
Do you know about the UNHLM declaration: |
|
Specializations / Areas of Work |
Delivery of health services and care Research and Development Technical Assistance |
Other Organization Information |
Total number of staff in your organization: |
6 - 10 |
Number of full-time staff who are directly involved with TB: |
1 - 5 |
Number of part-time staff who are directly involved with TB: |
0 |
Number of volunteers who are directly involved with TB: |
0 |
|
How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
Why do you wish join the Stop TB Partnership: |
Network with other partners |
|
Are you a member of a Stop TB national partnership: |
No |
Are you in contact with your national TB programme: |
Yes |
Please tell us how your organization is contributing to your country's national TB control plan: |
The Global Childhood TB Program supports TB activities within the Baylor International Pediatric AIDS Initiative (BIPAI) http://www.bipai.org/ in Romania, Tanzania, Malawi, Uganda, Botswana, Lesotho, and Swaziland. Other activities include Stop TB Partnership funded TB REACH projects involving intensified case finding in Lesotho, Swaziland, Sierra Leone; Childhood TB/HIV training for clinicians and National Tuberculosis Control Program (NTP) managers; implementation science; and translational and operational research |
|
Geographical Reach |
Which country is your headquarters located in: |
United States of America |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Botswana Eswatini Lesotho Malawi Papua New Guinea Philippines Romania Sierra Leone South Africa Uganda United Republic of Tanzania |
Contribution |
Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
TB Care Delivery: The Global Childhood TB Program uses partnerships with other members of the Baylor College of Medicine family and collaborators at other institutions to develop effective, sustainable, standardized methods of diagnosing tuberculosis in children and is attempting to identify biomarkers correlating with progression from tuberculosis infection to disease, as well as standardizing screening processes to better characterize epidemiological risk factors for tuberculosis. |
Declaration |
Declaration of interests:
No conflicts of interest were delacred.
|
Application date: |
May 19, 2014 |
Last updated: |
July 15, 2014 |
|